Cargando…
培美曲塞及吉西他滨分别联合顺铂治疗初治晚期非小细胞肺癌安全性和有效性的随机对照研究
BACKGROUND AND OBJECTIVE: Due to the various inter-individual differences in the biological characteristics of tumor cells, as well as issues on the efficacy, adverse reactions, and defects of existing drugs, we compared the clinical efficacy and toxicity of pemetrexed and gemcitabine combined with...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999833/ https://www.ncbi.nlm.nih.gov/pubmed/23075680 http://dx.doi.org/10.3779/j.issn.1009-3419.2012.10.02 |
Ejemplares similares
-
培美曲塞联合顺铂对比吉西他滨联合顺铂一线治疗晚期非鳞非小细胞肺癌的随机、对照、多中心临床研究
Publicado: (2012) -
吉非替尼对比培美曲塞二线治疗晚期非鳞型非小细胞肺癌的随机对照临床研究
Publicado: (2013) -
培美曲塞/顺铂二线治疗晚期非小细胞肺癌:一例报告及文献复习
Publicado: (2010) -
培美曲塞联合铂类对比吉西他滨联合铂类治疗晚期非小细胞肺癌的meta分析
Publicado: (2011) -
培美曲塞联合顺铂或卡铂治疗复发或转移性非小细胞肺癌63例疗效分析
Publicado: (2011)